Nanogen last week rolled out kits for the detection of Alzheimer’s disease, Canavan disease, and beta thalassemia. The Alzheimer’s and Canavan products are analyte-specific reagents for creating tests for mutations. All three products are used on NanoChip microarrays.
Nanogen
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.